Evidence map›Paper›PMID 28694332›Full record

ArticleMolecular and cellular biology2017

The Ets2 Repressor Factor (Erf) Is Required for Effective Primitive and Definitive Hematopoiesis.

Ioanna Peraki, James Palis, George Mavrothalassitis

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular and cellular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ioanna PerakiMedical School, University of Crete, Heraklion, Crete, Greece.
James PalisDepartment of Pediatrics, Center for Pediatric Biomedical Research, University of Rochester Medical Center, Rochester, New York, USA.
George MavrothalassitisMedical School, University of Crete, Heraklion, Crete, Greece mavro@imbb.forth.gr.ORCID http://orcid.org/0000-0001-6214-3179
University of Crete · GRUniversity of Rochester Medical Center · US

Funding

Erythroid precursor self-renewalR01HL130670 · NHLBI · UNIVERSITY OF ROCHESTER · PI PALIS, JAMES · 2015 to 2018
$1.8M
Embryonic hematopoietic stem cell origin and ontogenyR01DK060403 · NIDDK · UNIVERSITY OF ROCHESTER · PI PALIS, JAMES · 2001 to 2004
$1.7M
NHLBI NIH HHS R01 HL130670NIDDK NIH HHS R01 DK060403
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Embryonic DevelopmentAnemiaAnimalsCell DifferentiationCell LineageCell ProliferationEmbryo, MammalianErythroblastsGene Knockout TechniquesHematopoiesisHematopoietic Stem CellsHumansMiceRepressor ProteinsErf protein, mouseRepressor Proteinsanemiadefinitive wavedevelopmental biologydifferentiationembryoErffetal liverhematopoiesishemogenic endotheliumHSCsmouseprimitive wave

Identifiers

PMID28694332
PMCPMC5599724
OpenAlexW2735126736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.